ADHD
ADHD in young children in India: prevalence and public-health burden
ADHD (ICD-11 6A05) prevalence estimates among young children in India broadly range from about 2% to 8%, varying by age, setting and method. The greater public-health burden lies in under-recognition and late identification — making equitable developmental screening and reliable referral pathways the highest-return priority.
Policymakers ask the right question first: how many young children are affected, and what does it cost the system to act late?
In short
ADHD (ICD-11 6A05) is among the most common neurodevelopmental conditions of childhood, with community prevalence estimates in India broadly ranging from around 2% to 8% depending on age band, setting and screening method — higher in clinic-referred and school-based samples than in general population surveys. The genuine public-health burden, however, lies less in the headline figure and more in under-recognition, late identification and the downstream cost of unaddressed attention, learning and behaviour difficulties on schooling, family wellbeing and adult productivity. For young children specifically, the priority is reliable developmental screening and early routing — not premature labelling.The science and the burden, briefly
Prevalence figures vary widely because methods vary: diagnostic criteria (ICD-11 vs DSM), informant (parent vs teacher), age, and whether a sample is community-based or clinic-referred. This heterogeneity is itself a policy signal — it points to inconsistent screening pathways rather than a single true number. The burden in India is shaped by three structural gaps: low population-level awareness, a shortage of trained developmental clinicians relative to need, and fragmented links between schools, primary care and specialist assessment. Left unaddressed, ADHD in childhood is associated with poorer educational attainment, secondary emotional difficulties and higher long-term economic cost — which is precisely why early, equitable screening infrastructure delivers a strong public-health return.What public systems can act on
- Embed brief, validated developmental screening into existing child-health and school touchpoints rather than waiting for crisis-point referral.
- Strengthen referral pathways so a positive screen reliably reaches qualified clinical assessment.
- Invest in workforce and parent awareness to close the recognition gap, especially in under-served districts.
The Pinnacle way
A clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre, under qualified clinician care — never from a survey, an app or a screening number. As sovereign developmental-care infrastructure spanning 70+ centres across 4 states, 700+ therapists and 4.95 lakh+ families served, Pinnacle partners with public systems to convert screening into structured pathways. Explore ADHD support, the behavioural therapy pathway, and how the AbilityScore® is established.Trusted sources
WHO ICD-11 classifies ADHD under 6A05. The Indian Academy of Pediatrics and the American Academy of Pediatrics (HealthyChildren.org) provide guidance on recognition and care, while NICE NG87 sets out diagnosis and management standards and CDC's developmental-milestone resources support early identification.Next step — Government and institutional partners can build screening-to-care pathways with Pinnacle.
This is general information, not a diagnosis — a clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre under qualified clinician care.
What to watch
Watch for persistent inattention, overactivity or impulsivity that appears across more than one setting (home and school), is beyond what is typical for the child's age, and interferes with learning or relationships — and for these to persist over time rather than in a single difficult week.
Try this at home
At population level, the most reliable early signal is the parent or teacher who repeatedly notices a child struggling to settle, attend or follow routines across settings — capturing that concern in a structured screen, rather than dismissing it, is what closes the recognition gap.
Trusted sources
Developed by SETU Consortium · Pinnacle Blooms Network · Last reviewed 2026-06-10 · reviewed every 365 days
This is general information, not a diagnosis. A clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre, under qualified clinician care.
Frequently asked
Why do ADHD prevalence figures for India vary so much?
Estimates differ because studies use different diagnostic criteria (ICD-11 vs DSM), different informants (parent vs teacher), different age bands, and community versus clinic-referred samples. This variation reflects inconsistent screening pathways more than a single true rate, which is itself a policy signal.
Should young children be screened for ADHD at population level?
Brief, validated developmental screening embedded in routine child-health and school touchpoints is appropriate and useful. Screening is not diagnosis, however — a positive screen should route reliably to qualified clinical assessment rather than result in a label.
What is the main public-health burden of ADHD in India?
The burden lies largely in under-recognition, late identification and fragmented referral, which carry downstream costs in education, family wellbeing and long-term productivity. Early, equitable screening infrastructure delivers a strong public-health return.
Where is an ADHD diagnosis actually made?
A clinical AbilityScore® and any diagnosis are established only at a Pinnacle Blooms Network centre under qualified clinician care — never from a screening tool, survey or app.